The ApoCorrect assay: A novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5

Analytical Biochemistry

Volumn 327, Issue 1, 2004, Pages 126-134

  Boersma, Hendrikus H ^a   Stolk, Leo M L ^a   Kenis, Heidi ^b   Deckers, Niko M ^b   Vanderheyden, Jean Luc ^c   Hofstra, Leo ^a   Heidendal, Guido A K ^a   Reutelingsperger, Chris P M ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Theseus Imaging Corporation   (United States)

Author keywords

99mTc Annexin A5; Functional assay; Magnetic beads; Quality control; Thin layer chromatography

Indexed keywords

AMINO ACIDS; BINDING SITES; CELL DEATH; PHOSPHOLIPIDS; QUALITY CONTROL; THIN LAYER CHROMATOGRAPHY;

ACTIVE FRACTION; ANNEXIN A5; FUNCTIONAL ASSAYS; MAGNETIC BEADS; METHODS OF QUALITY CONTROL; PARAMAGNETIC BEADS; PROGRAMMED CELL DEATHS; STABILITY-INDICATING;

ANTIBIOTICS;

CALCIUM ION; FLUORESCENT DYE; LIPOCORTIN 5 TC 99M; PHOSPHATIDYLSERINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ACCURACY; APOCORRECT ASSAY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ASSAY; HALF LIFE TIME; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN BINDING; QUALITY CONTROL; REPRODUCIBILITY; SOLID; VALIDATION PROCESS;

EID: 1642285054     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.01.004     Document Type: Article

References (23)

1. Leist M., Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol. 2:2001;589-598.
2. McLaughlin R., Kelly C.J., Kay E., Bouchier-Hayes D. The role of apoptotic cell death in cardiovascular disease. Ir. J. Med. Sci. 170(2):2001;132-140.
3. Mattson M.P., Duan W., Pedersen W.A., Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 6(1-2):2001;69-81.
4. Kerr J.F., Winterford C.M., Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73(8):1994;2013-2026.
5. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216.
6. Gerke V., Moss S.E. Annexins: from structure to function. Physiol. Rev. 82(2):2002;331-371.
7. Tait J.F., Gibson D., Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J. Biol. Chem. 264(14):1989;7944-7949.
8. Andree H.A.M., Reutelingsperger C.P.M., Hauptmann R., Hemker H.C., Hermens W.Th., Willems G.M. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265:1990;4923-4928.
9. Blackwood R.A., Ernst J.D. Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem. J. 266(1):1990;195-200.
10. Blankenberg F.G., Katsikis P.D., Tait J.F., Davis E.R., Naumovski L., Ohtsuki K., Kopiwoda S., Abrams M.J., Darkes M., Robbins R.C., Maecker H.T., Strauss H.W. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA. 95:1998;6349-6354.
11. Blankenberg F.G., Tait J.F., Strauss H.W. Apoptotic cell death: its implications for imaging in the next millenium. Eur. J. Nucl. Med. 27:2000;359-367.
12. Hofstra L., Liem I.H., Dumont E.A., Boersma H.H., van Heerde W.L., Doevendans P.A., De Muinck E., Wellens H.J., Kemerink G.J., Reutelingsperger C.P., Heidendal G.A. Visualisation of apoptosis in vivo in patients with an acute myocardial infarction. Lancet. 356:2000;209-212.
13. Narula J., Acio E.R., Narula N., Samuels L.E., Fyfe B., Wood D., Fitzpatrick J.M., Raghunath P.N., Tomaszewski J.E., Kelly C., Steinmetz N., Green A., Tait J.F., Leppo J., Blankenberg F.G., Jain D., Strauss H.W. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat. Med. 7(12):2001;1347-1352.
14. Hofstra L., Dumont E.A., Thimister P.W.L., Heidendal G.A., de Bruïne A.P., Elenbaas T.W., Boersma H.H., van Heerde W.L., Reutelingsperger C.P. In vivo detection of apoptosis in an intracardiac tumor. J. Am. Med. Assoc. 285:2001;1841-1842.
15. 99mTc-Annexin A5. Br. J. Radiol. 76:2003;553-560.
16. 2+-binding site in the mechanism of inhibition. J. Biol. Chem. 272(16):1997;10474-10482.
17. 99mTc-derivatized Annexin V for human use. Nucl. Med. Biol. 30:2003;771-778.
18. Belhocine T., Steinmetz N., Hustinx R., Bartsch P., Jerusalem G., Seidel L., Rigo P., Green A. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 8:2002;2766-2774.
19. 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J. Nucl. Med. 44:2003;947-952.
20. van de Wiele C., Lahorte C., Vermeersch H., Loose D., Mervillie K., Steinmetz N.D., Vanderheyden J.L., Cuvelier C.A., Slegers G., Dierck R.A. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J. Clin. Oncol. 21:2003;3483-3487.
21. Dumont E.A., Hofstra L., van Heerde W.L., van den Eijnde S.M., Doevendans P.A., de Muinck E., Daemen M.A., Smits J.F., Frederik P., Wellens H.J., Daemen M.J., Reutelingsperger C.P. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation. 102:2000;1564-1568.
22. van den Eijnde S.M., van den Hoff M.J., Reutelingsperger C.P., van Heerde W.L., Henfling M.E., Vermeij-Keers C., Schutte B., Borgers M., Ramaekers F.C. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 114:2001;3631-3642.
23. Köhler G., Hering U., Zschörnig O., Arnold K. Annexin V interaction with phosphatidylserine-containing vesicles at low and neutral pH. Biochemistry. 36:1997;8189-8194.